{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:36:32Z","timestamp":1786743392939,"version":"build-2736575974"},"reference-count":30,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Type 2 respiratory failure (T2RF) is a common and high-risk presentation in the emergency department (ED). Noninvasive positive pressure ventilation (NIPPV) is a standard first-line therapy for T2RF, particularly in acute exacerbations of chronic obstructive pulmonary disease and cardiogenic pulmonary edema. However, NIPPV has limitations, including discomfort, claustrophobia, air leaks, skin injury, and aspiration that may compromise tolerance and lead to treatment failure or escalation to endotracheal intubation. High-velocity nasal insufflation (HVNI), particularly via a single-prong asymmetric cannula configuration, has been proposed to enhance dead-space washout and improve patient comfort. Despite growing interest, robust evidence of evaluation of HVNI in heterogeneous, all-cause T2RF populations in the ED remains limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to determine whether HVNI delivered via a single-prong nasal cannula is noninferior to standard NIPPV in improving ventilation among adult ED patients with T2RF from any cause.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This is a single-center, open-label, noninferiority randomized controlled trial conducted in the ED of a tertiary academic center. Adults aged 21 years and above with T2RF, defined as partial pressure of carbon dioxide (PaCO\n 2<\/jats:sub>\n ) above 45 mm Hg and pH below 7.35 requiring ventilatory support, will be randomized 1:1 to HVNI via a single-prong cannula or standard NIPPV. Allocation will be concealed via an independent web-based platform using variable block sizes. The primary outcome is percentage change in PaCO\n 2<\/jats:sub>\n from baseline to 60 minutes after initiation of therapy. A total of 84 patients provide 80% power and one-sided \u03b1 of 2.5% assuming an SD of 6.65% and noninferiority margin of 4.3%. Analyses will use intention-to-treat and per-protocol approaches, and sensitivity analyses to address missing arterial blood gas results will be conducted. Predefined failure criteria (persistent or worsening acidosis, rising PaCO\n 2<\/jats:sub>\n , refractory hypoxemia, severe intolerance, and clinical deterioration) will trigger crossover or escalation per protocol.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Ethics approval was granted by the local institutional ethics board on February 24, 2025 (reference 2024-4329). Recruitment commenced in January 2026 and is expected to be completed by June 2027. As of July 2026, a total of 19 participants have been enrolled out of a target sample of 84. Data analysis will commence following completion of enrollment, with results expected to be published by 2028.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Should HVNI via a single-prong cannula be shown to be noninferior to NIPPV, it may offer a practical alternative to treatment of T2RF in the ED when mask-based interfaces are poorly tolerated or contraindicated, potentially reducing the need for more invasive interventions such as endotracheal intubation and mechanical ventilation.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/93391","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:25:05Z","timestamp":1785317105000},"page":"e93391-e93391","source":"Crossref","is-referenced-by-count":0,"title":["Study of High-Velocity Nasal Insufflation vs Noninvasive Positive Pressure Ventilation for Emergency Type 2 Respiratory Failure: Protocol for a Noninferiority Randomized Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-4914","authenticated-orcid":false,"given":"Mui Teng","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-7618","authenticated-orcid":false,"given":"Darius Shaw Teng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8673-6679","authenticated-orcid":false,"given":"Alexander Jet Yue","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7101-2221","authenticated-orcid":false,"given":"Crystal Harn Wei","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2134-7842","authenticated-orcid":false,"given":"Win Sen","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2023.100007","article-title":"Supporting patients with hypercapnia","volume":"24","author":"Tregidgo","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/resp.14388","article-title":"Causes of hypercapnic respiratory failure and associated in-hospital mortality","volume":"28","author":"Chung","journal-title":"Respirology"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02426-2016","article-title":"Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure","volume":"50","author":"Rochwerg","journal-title":"Eur Respir J"},{"issue":"4","key":"R4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/emj.2007.049072","article-title":"Non-invasive ventilation and continuous positive pressure ventilation in emergency departments: where are we now?","volume":"25","author":"Bolton","journal-title":"Emerg Med J"},{"issue":"142","key":"R5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1183\/16000617.0002-2016","article-title":"Experiences of noninvasive ventilation in adults with hypercapnic respiratory failure: a review of evidence","volume":"25","author":"Ngandu","journal-title":"Eur Respir Rev"},{"issue":"2","key":"R6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/emj.17.2.79","article-title":"Review of the role of non-invasive ventilation in the emergency department","volume":"17","author":"Cross","journal-title":"J Accid Emerg Med"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.47102\/annals-acadmedsg.2020331","article-title":"Emergency airway management in a Singapore centre: a registry study","volume":"50","author":"Chan","journal-title":"Ann Acad Med Singap"},{"issue":"9","key":"R8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/jeccm.2017.08.06","article-title":"The use of high-flow nasal cannula in acute decompensated heart failure: ready for prime time yet?","volume":"1","author":"Chua","journal-title":"J Emerg Crit Care Med"},{"issue":"23","key":"R9","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"Frat","journal-title":"N Engl J Med"},{"issue":"5","key":"R10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00134-019-05590-5","article-title":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"45","author":"Rochwerg","journal-title":"Intensive Care Med"},{"issue":"1","key":"R11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04218-3","article-title":"High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials","volume":"26","author":"Ovtcharenko","journal-title":"Crit Care"},{"issue":"3","key":"R12","first-page":"E92","volume":"67","author":"Miyazaki","journal-title":"Kobe J Med Sci"},{"issue":"5","key":"R13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.hrtlng.2020.03.008","article-title":"The ventilatory effect of high velocity nasal insufflation compared to non-invasive positive-pressure ventilation in the treatment of hypercapneic respiratory failure: a subgroup analysis","volume":"49","author":"Doshi","journal-title":"Heart Lung"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.annemergmed.2017.12.006","article-title":"High-velocity nasal insufflation in the treatment of respiratory failure: a randomized clinical trial","volume":"72","author":"Doshi","journal-title":"Ann Emerg Med"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001209","article-title":"Effect of single-prong cannula design with high velocity therapy: comparable efficacy at lower gas flow rates","volume":"7","author":"Atwood","journal-title":"Crit Care Explor"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1263-z","article-title":"Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure","volume":"20","author":"Roca","journal-title":"Crit Care"},{"issue":"8","key":"R17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4187\/respcare.01106","article-title":"The effects of flow on airway pressure during nasal high-flow oxygen therapy","volume":"56","author":"Parke","journal-title":"Respir Care"},{"issue":"4","key":"R18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02339-2018","article-title":"Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks","volume":"53","author":"Hui","journal-title":"Eur Respir J"},{"issue":"8","key":"R19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1164\/rccm.202006-2309OC","article-title":"Aerosol generation from the respiratory tract with various modes of oxygen delivery","volume":"202","author":"Gaeckle","journal-title":"Am J Respir Crit Care Med"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081660","article-title":"SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials","volume":"389","author":"Hr\u00f3bjartsson","journal-title":"BMJ"},{"key":"R21","unstructured":"Chapter 5.8: consent for research in emergency situations. In: NHG Health Investigator Manual \u2013 All That an Investigator Needs to Know. 5th ed. NHG Health; 2025:21-24. URL: https:\/\/ethics.gri.nhg.com.sg\/files\/Investigator%20Manual\/NHG_Health_Investigator_Manual.pdf [Accessed 03-08-2026]"},{"key":"R22","unstructured":"Randomisation and online databases for clinical trials. Sealed Envelope. URL: https:\/\/www.sealedenvelope.com\/ [Accessed 07-08-2026]"},{"issue":"7644","key":"R23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","journal-title":"BMJ"},{"key":"R24","unstructured":"Validity of outcome measures. Riociguat (Adempas): Management of Inoperable Chronic Thromboembolic Pulmonary Hypertension [Internet]. Canadian Agency for Drugs and Technologies in Health; 2015. URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK349358 [Accessed 10-12-2025]"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Korn EL Freidlin B . Clinical trial designs in oncology. In: Abeloff\u2019s Clinical Oncology. 6th ed. Elsevier; 2020:296-307. [doi: 10.1016\/B978-0-323-47674-4.00018-9]","DOI":"10.1016\/B978-0-323-47674-4.00018-9"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/crj.13315","article-title":"Comparison of high-flow oxygenation with noninvasive ventilation in COPD exacerbation: a crossover clinical trial","volume":"15","author":"Rezaei","journal-title":"Clin Respir J"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","journal-title":"BMJ"},{"issue":"24","key":"R28","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement","volume":"308","author":"Piaggio","journal-title":"JAMA"},{"issue":"Suppl 2","key":"R29","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-208209","article-title":"BTS\/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults","volume":"71 Suppl 2","author":"Davidson","journal-title":"Thorax"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1152\/japplphysiol.00058.2022","article-title":"Revisiting the effects of the reciprocal function between alveolar ventilation and CO partial pressure (PACO2) on PACO2 homeostasis at rest and in exercise","volume":"133","author":"Haouzi","journal-title":"J Appl Physiol (1985)"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:12:07Z","timestamp":1786741927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e93391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2196\/93391","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"v15i1e93391"}}